A reduction in renal function is associated with high cardiovascular morbidity and mortality in hypertension. The aim of the present study was to investigate the relationship between creatinine clearance and subclinical organ damage in 957 never previously treated, middle-aged patients with primary hypertension. Renal function was estimated by means of the serum creatinine level using the Cockcroft-Gault formula; left ventricular hypertrophy (LVH) was determined according to electrocardiographic criteria; and retinal vascular changes were evaluated by direct ophthalmoscopy. Creatinine clearance was, on the average, 83721.2 ml/ min, and the prevalence of LVH and retinopathy was 13 and 49%, respectively. Creatinine clearance was inversely related to the duration of disease (r ¼ À0.132, Po0.0001), systolic blood pressure (r ¼ À0.110, P ¼ 0.001), serum glucose (r ¼ À0.090, P ¼ 0.007), total cholesterol (r ¼ À0.196, Po0.0001), and LDL-cholesterol (r ¼ À0.196, Po0.0001). Patients in the lower quintile of creatinine clearance showed a higher prevalence of electrocardiogram (ECG) determined LVH (P ¼ 0.04), as well as retinal changes (P ¼ 0.02). The risk of having LVH or retinal vascular changes increases significantly with each s.d. decrease in creatinine clearance, regardless of traditional cardiovascular risk factors. Moreover, patients with ECG-determined LVH and retinal changes showed lower creatinine clearance as compared to those with lesser degrees of target organ involvement (Po0.01).
Introduction
Mild renal dysfunction, that is, a small increase in serum creatinine below 2 mg/dl, and/or the presence of abnormal urinary albumin excretion, is a powerful predictor of cardiovascular events in hypertensive patients. 1, 2 The pathophysiological mechanisms underlying this association have not yet been fully elucidated, although they likely involve a number of different factors. In fact, it has been shown that a moderate reduction in glomerular filtration rate is associated with a cluster of haemodynamic and proatherogenic abnormalities, such as increased blood pressure (BP) load, insulin resistance, dyslipidaemia, hyperhomocysteinaemia, endothelial dysfunction, and systemic inflammation, which, in turn, may concur to foster the development of cardiac and vascular complications. [3] [4] [5] Creatinine clearance is a more sensitive measurement of kidney function as compared to serum creatinine, and can be easily estimated even in the absence of 24-h urine collection by using prediction equations, such as the Cockcroft-Gault formula. 6 Previous studies demonstrated an association between a moderate reduction in creatinine clearance (o60 ml/min) and increased risk of cardiovascular events. 7 Left ventricular hypertrophy (LVH) is a wellestablished, independent predictor of future cardiovascular complications, 8 and therefore its presence strongly influences the global risk profile. Owing to its prognostic value, wide availability, and costeffectiveness, the electrocardiogram is currently recommended as first-line testing in the diagnostic work-up of every hypertensive patient. 9, 10 The role and specificity of funduscopic examination in the detection of target organ damage is currently a matter of debate. However, even mild retinal vascular changes have proven to be of predictive value. 11 Therefore, funduscopy, which is a relatively inexpensive and easy to perform examination, may be a useful tool in the evaluation of risk in hypertensive patients.
An association between a decrease in creatinine clearance and hypertensive end-organ damage is, therefore, of potential interest since it may help explain the high morbidity and mortality observed in patients with mild renal dysfunction. Furthermore, it could shed some light on the pathogenesis of hypertensive organ damage. In the present study, we have therefore evaluated the relationship between creatinine clearance and early signs of target organ damage, namely LVH and retinal vascular changes in a large group of untreated, unselected patients with primary hypertension and normal serum creatinine.
Subjects and methods

Selection of patients
Between January 1996 and January 2001, all previously untreated patients with primary hypertension attending the outpatient clinic of our institution were asked to participate in this study, which was part of a larger trial (MAGIC: Microalbuminuria: A Genoa Investigation on Complications) approved by the Ethical Committee of our department. Details of the study have already been published. 12 Exclusion criteria included the presence of neoplastic, hepatic and/or renal disease (serum creatinine 41.4 mg/dl for females and 41.5 mg/dl for males and/or proteinuria 4300 mg/ 24 h), chronic heart failure (NYHA classes III and IV), a positive history or clinical signs of ischaemic heart disease, diabetes mellitus, severe obesity (defined as body weight 4150% of the ideal body weight), and/or disabling diseases such as dementia or inability to co-operate. The diagnosis of essential hypertension was made by the attending physician after a complete medical history, physical examination, and routine biochemical analyses of blood and urine were obtained from each patient. Further investigation was carried out only when abnormalities were found in these analyses, or when other symptoms or signs suggesting secondary hypertension were present. Hypertension was defined as an average BP X140/90 mmHg on at least two different occasions. Altogether, 1061 hypertensive patients were seen at our clinic within the above-mentioned time range, and among them 987 (93%) were eligible for the study on the basis of available clinical and laboratory data. Of these, 14 patients did not meet study criteria based on the results of additional tests prescribed for clinical reasons during their first visit to our clinic. Among the remaining 973 patients (all Caucasian Europeans), 16 declined, thus 957 form the basis of the present report. A total of 201 (21%) of the participating patients had received antihypertensive treatment in the past, albeit intermittently and not over the last 6 months. After obtaining written informed consent, all patients underwent the following procedures: (1) clinical BP measurement; (2) blood and urine sampling; (3) standard 12-lead electrocardiogram (ECG); and (4) direct ophthalmoscopy. On the study day, after an overnight fasting, height and weight were measured and venous blood was drawn. BP was measured by a trained nurse, with the patient in the sitting position after a 5-min rest, with a mercury sphygmomanometer (cuff size 12.5 Â 40 cm). The systolic (SBP) and diastolic blood pressures (DBP) were read to the nearest 2 mmHg. Disappearance of Korotkoff's sounds (phase V) was the criterion for diastolic BP. The lowest of three consecutive readings was recorded. Creatinine, blood urea nitrogen, electrolytes, uric acid, triglycerides, total and high-density lipoprotein (HDL)-cholesterol, and other standard blood chemistry evaluations were performed on serum according to routine methods. Serum creatinine levels were measured by the Jaffé method using a Synchron CX3 Clinical System Beckman analyzer. Low-density lipoprotein (LDL)-cholesterol was calculated using Friedewald's formula. The presence of microalbuminuria was evaluated in each patient by measuring the albumin to creatinine ratio (ACR) on three non consecutive first morning samples as described in Pontremoli et al. 12 In order to account for differences in basal creatinine excretion rates and body mass index (BMI), different values were used to define microalbuminuria in males (ACRX2.5 mg/mmol) and in female subject (ACRX3.5 mg/mmol). Family history and lifestyle habits were assessed by means of a standard questionnaire.
Creatinine clearance
Creatinine clearance was estimated by the Cockcroft-Gault equation, 6 which derives the value from creatinine concentration, age, gender, and ideal body weight.
Electrocardiography
Standard 12-lead ECG were recorded at 25 mm/s, 1 mV/cm calibration. A single experienced cardiologist blinded to clinical information evaluated all tracings in order to detect LVH. LVH was defined by the presence of at least one of two electrocardiographic criteria: the Sokolow-Lyon voltage 13 and the gender-specific Cornell voltageduration product. 14 
Direct ophthalmoscopy
The presence, type, and extent of hypertensive retinopathy were investigated in a darkened room, under pupil dilatation. Direct ophthalmoscopy was carried out with a halogen ophthalmoscope; the first arteriovenous crossing that was at least one disc diameter from the disc in each quadrant was selected and assessed. Each quadrant of the fundus was photographed by means of a Zeiss fundus camera (Oberkochen, Germany) with a 301 field. Photographic slides were projected and evaluated by the same ophthalmologist, who was unaware of the patients' clinical data. Intraobserver variability in the determination of retinal abnormalities was low, with 85% agreement for narrowing, 90% for arteriolar light reflex and sclerosis, and 100% for arteriovenous crossing. Retinal lesions were classified according to the Keith-Wagener-Barker classification. 15 The presence of retinal abnormalities, such as arteriolar narrowing and mild sclerosis (grade I), or widened arteriolar light reflex, moderate to marked sclerosis, and arterio-venous crossing (grade II) were considered markers of target organ damage. 10 
Statistical analysis
All data are expressed as mean 7s.d. Study patients were analysed on the basis of the distribution of creatinine clearance values (quintiles). Differences between variables were assessed using the appropriate statistical test based on the underlying distribution of the variables. One-way analysis of variance (ANOVA) with Bonferroni's or Tukey's multiple comparison post-test (as appropriate) was used to analyse data from patients with various degrees of creatinine clearance, and with or without end-organ damage. Relations among variables were assessed using linear regression analysis and Pearson's correlation coefficient. Comparison of proportion among groups was performed using the w 2 -test. The relative risk and 95% confidence intervals for variation in LVH and retinal vascular changes were calculated by exponentiation of logistic regression coefficients. All statistical analyses were performed using Statview for Windows (SAS Institute Inc., version 5.0.1, Cary, NC, USA). Po0.05 was considered statistically significant.
Results
The main clinical characteristics of the study patients are reported in Table 1 . The mean creatinine clearance was 83721.2 ml/min and the overall prevalence of LVH and retinal vascular changes was 13 and 49%, respectively. In particular, grades I and II retinopathy was present in 24 and 25% of patients, respectively. Significant univariate correlations between creatinine clearance and selected clinical variables in the entire study group are shown in Table 2 . Lower creatinine clearance was associated with longer reported duration of disease, higher SBP, serum glucose, total cholesterol, LDLcholesterol, and to early signs of target organ damage, namely LVH and retinal vascular changes.
No relation was found between creatinine clearance and urinary albumin excretion. Furthermore, patients in the lower quintile of creatinine clearance showed significantly worse risk profiles (ie, older age, higher SBP, reported duration of disease, and total cholesterol) as well as higher prevalence of LVH (P ¼ 0.04) and retinal vascular changes (P ¼ 0.02) (Figure 1a, b) . The relationship between creatinine clearance and the presence of LVH and retinal vascular changes was also assessed by logistic regression models. Lower creatinine clearance was associated with an increased prevalence of LVH and retinal vascular changes in multivariate models with controls for mean blood pressure, body mass index, reported duration of disease, and total cholesterol. Each s.d. reduction in creatinine clearance entails a 20% increase in the risk of having cardiac or retinal abnormalities (Table 3) . Moreover, the association between creatinine clearance and subclinical organ damage was related to the extension of cardiovascular involvement. In fact, patients with both LVH and retinal vascular changes showed lower creatinine clearance as compared to those with only one of these abnormalities (Po0.01) (Figure 2 ). Creatinine clearance and hypertensive organ damage G Leoncini et al
Discussion
The present study demonstrates that a mild reduction in creatinine clearance is associated with subclinical organ damage, namely LVH and retinal vascular changes in a large group of patients with primary hypertension and normal serum creatinine. These data are relevant to previous reports, which showed an association between mild renal dysfunction and adverse cardiovascular prognosis in hypertensive patients. In the Hypertension Detection and Follow-up Program trial, a linear relation between serum creatinine and cardiovascular mortality was observed over a 5-year follow-up, with a 2 times higher risk of mortality in patients with serum creatinine 41.7 mg/dl at baseline. 16 More recently, in the HOT study a slight increase in serum creatinine was associated with a 3.2 times greater incidence of fatal events, regardless of common cardiovascular risk factors. 7 Similar findings have also been reported by using creatinine clearance as an estimate of the glomerular filtration rate in patients with isolated systolic hypertension, 17 and in those with concomitant cardiovascular risk factors participating in the HOPE Study. 18 Creatinine clearance provides a more sensitive estimate of glomerular filtration rate as compared to serum creatinine, 19 since it is corrected for body weight, gender, and age, which are variables known for influencing creatinine values.
Thus, in our study the use of creatinine clearance proved to be a very sensitive marker of subclinical cardiac and vascular damage. In fact, despite similar serum creatinine levels, patients in the bottom quintile of clearance showed a higher prevalence of ECG-detected LVH and retinopathy (Figure 1 ). Also included in the model: total cholesterol, and mean BP, which are not significantly related to retinal vascular changes.
Creatinine clearance and hypertensive organ damage G Leoncini et al LVH can be found in 10-45% of hypertensive patients 20 and, therefore, the prevalence of LVH reported in our study is in line with previous findings from larger trials that used similar criteria. 21, 22 Owing to its low cost, wide availability, and powerful prognostic value, ECG is currently the recommended screening test for LVH detection in hypertensive patients. 10, 11 The usefulness of evaluating retinal vascular changes is currently more controversial. 23 Recent evidence, however, supports the prognostic role that hypertensive abnormalities detected at fundoscopic examination may have. 24, 25 In our study population, the association we observed between a reduction in creatinine clearance and cardiovascular involvement was rather linear and graded. In fact, patients with simultaneous LVH and retinal vascular changes showed significantly lower creatinine clearance as compared to those with only one of these abnormalities (Figure 2) . Moreover, patients with creatinine clearance below 60 ml/min were 2 times more likely to have both LVH and retinal vascular changes as compared to those with higher creatinine clearance (data not shown).
Hypertensive target organ damage is a powerful, independent predictor of cardiovascular complications, and often precedes and predicts the occurrence of major events. Thus, the association that we found between moderate reduction of renal function and both LVH and retinal vascular changes provides a useful, albeit indirect insight into the mechanisms leading to cardiovascular disease. In our study, a decrease in creatinine clearance entailed the concomitant presence of several haemodynamic and proatherogenic abnormalities, that is, higher levels of SBP, serum glucose, and LDL-cholesterol (Table 2) . This finding is consistent with previous reports and strengthens the concomitant role of multiple risk factors in the development of cardiovascular damage in patients with renal disease. 3 Undoubtedly, age may play an important confounding role in the association we observed between creatinine clearance and target organ damage, although one that is technically difficult to assess because age is part of the formula that is used to evaluate creatinine clearance. It is noteworthy that the relationship between creatinine clearance and target organ damage was in part independent of traditional cardiovascular risk factors, namely high blood pressure levels, dyslipidaemia, increased body weight, and history of hypertension, as suggested by results of logistic regression analysis (Table 3) . Thus, it would appear that factors that are unknown or unaccounted for in our study play a role in the pathogenesis of hypertensive end-organ damage.
In conclusion, our results show that a reduction in creatinine clearance is a marker of subclinical organ damage in patients with primary hypertension and normal serum creatinine. Although our study does not directly assess the usefulness of creatinine clearance in identifying patients at cardiovascular risk, we suggest that due to the ready availability and low cost, this test should be routinely performed not only to assess renal function but also to obtain a more sensitive evaluation of cardiovascular damage in hypertensive patients.
